Treatment of ovarian hyperstimulation syndrome

Seminars in Reproductive Medicine

Volumn 28, Issue 6, 2010, Pages 532-539

  Aboulghar, Mohamed ^a,b  

^a CAIRO UNIVERSITY   (Egypt)

^b The Egyptian IVF Center   (Egypt)

Author keywords

aspiration of ascitic fluid; hydroxyethyl starch; IV albumin; OHSS treatment

Indexed keywords

ALBUMIN; ANTIBIOTIC AGENT; CABERGOLINE; DOCARPAMINE; FUROSEMIDE; GONADORELIN; HEPARIN; HETASTARCH; INFUSION FLUID;

ASCITES FLUID; CONSERVATIVE TREATMENT; CREATININE BLOOD LEVEL; CRYSTALLOID; DISEASE SEVERITY; DIURESIS; ELECTROLYTE DISTURBANCE; HEALTH CARE COST; HEMATOCRIT; HOSPITALIZATION; HUMAN; HYDROTHORAX; INTENSIVE CARE; KIDNEY FUNCTION; LIVER FUNCTION; OUTPATIENT CARE; OVARY HYPERSTIMULATION; PARACENTESIS; RESPIRATORY DISTRESS; REVIEW; VEIN THROMBOSIS;

ALGORITHMS; DRAINAGE; FEMALE; FLUID THERAPY; HUMANS; INFUSIONS, INTRAVENOUS; OVARIAN HYPERSTIMULATION SYNDROME; OVULATION INDUCTION; PREGNANCY; SEVERITY OF ILLNESS INDEX;

EID: 78649245718     PISSN: 15268004     EISSN: 15264564     Source Type: Journal    
DOI: 10.1055/s-0030-1265681     Document Type: Review

References (46)

1. Rizk B, Aboulghar M. Modern management of ovarian hyperstimulation syndrome. Hum Reprod 1991 6 (8) 1082-1087
2. Delvigne A, Rozenberg S. Review of clinical course and treatment of ovarian hyperstimulation syndrome (OHSS). Hum Reprod Update 2003 9 (1) 77-96
3. Borenstein R, Elhalah U, Lunenfeld B, Schwartz Z S. Severe ovarian hyperstimulation syndrome: a reevaluated therapeutic approach. Fertil Steril 1989 51 (5) 791-795
4. Aboulghar M A., Mansour R T., Serour G I., Sattar M A., Amin Y M., Elattar I. Management of severe ovarian hyperstimulation syndrome by ascitic fluid aspiration and intensive intravenous fluid therapy. Obstet Gynecol 1993 81 (1) 108-111
5. Aboulghar M A., Mansour R T. Ovarian hyperstimulation syndrome: classifications and critical analysis of preventive measures. Hum Reprod Update 2003 9 (3) 275-289
6. Rizk B, Aboulghar M. Classification, pathophysiology and management of ovarian hyperstimulation syndrome In: Brinsden P In Vitro Fertilization and Assisted Reproduction. London, United Kingdom Taylor and Francis 1995 217-258
7. Navot D, Bergh P A., Laufer N et al. The ovarian hyperstimulation syndrome In: Adashe EY, Rock JA, Rosenwaks Z Reproductive Endocrinology, Surgery, and Technology. Philadelphia, PA Lippincott-Raven 1996 2225-2232
8. Balasch J, Fábregues F, Arroyo V, Jiménez W, Creus M, Vanrell J A. Treatment of severe ovarian hyperstimulation syndrome by a conservative medical approach. Acta Obstet Gynecol Scand 1996 75 (7) 662-667
9. Abdalla HI, Rizk B Assisted Reproductive Technology. Abingdon, Oxford, United Kingdom Health Press 2004 37-39
10. Schenker J G. Prevention and treatment of ovarian hyperstimulation. Hum Reprod 1993 8 (5) 653-659
11. Fábregues F, Balasch J, Manau D et al. Haematocrit, leukocyte and platelet counts and the severity of the ovarian hyperstimulation syndrome. Hum Reprod 1998 13 (9) 2406-2410
12. Kodama H, Fukuda J, Karube H, Matsui T, Shimizu Y, Tanaka T. Characteristics of blood hemostatic markers in a patient with ovarian hyperstimulation syndrome who actually developed thromboembolism. Fertil Steril 1995 64 (6) 1207-1209
13. Shapiro A G., Thomas T, Epstein M. Management of hyperstimulation syndrome. Fertil Steril 1977 28 (3) 237-239
14. Kissler S, Neidhardt B, Siebzehnrübl E, Schmitt H, Tschaikowsky K, Wildt L. The detrimental role of colloidal volume substitutes in severe ovarian hyperstimulation syndrome: a case report. Eur J Obstet Gynecol Reprod Biol 2001 99 (1) 131-134
15. Abramov Y, Fatum M, Abrahamov D, Schenker J G. Hydroxyethyl starch versus human albumin for the treatment of severe ovarian hyperstimulation syndrome: a preliminary report. Fertil Steril 2001 75 (6) 1228-1230
16. Rabinerson D, Ben Rafael Z, Keslin J, Zolotarsky V, Dekel A. 10% hydroxyethyl starch for plasma expansion in the treatment of severe ovarian hyperstimulation syndrome. A case report. J Reprod Med 2001 46 (1) 68-70
17. Gamzu R, Almog B, Levin Y, Avni A, Lessing J B., Baram A. Efficacy of hydroxyethyl starch and Haemaccel for the treatment of severe ovarian hyperstimulation syndrome. Fertil Steril 2002 77 (6) 1302-1303
18. Aboulghar M A., Mansour R T., Serour G I., Amin Y. Ultrasonically guided vaginal aspiration of ascites in the treatment of severe ovarian hyperstimulation syndrome. Fertil Steril 1990 53 (5) 933-935
19. Ferraretti A P., Gianaroli L, Diotallevi L, Festi C, Trounson A. Dopamine treatment for severe ovarian hyperstimulation syndrome. Hum Reprod 1992 7 (2) 180-183
20. Tsunoda T, Shibahara H, Hirano Y et al. Treatment for ovarian hyperstimulation syndrome using an oral dopamine prodrug, docarpamine. Gynecol Endocrinol 2003 17 (4) 281-286
21. Rollene N L., Amols M H., Hudson S BA, Coddington C C. Treatment of ovarian hyperstimulation syndrome using a dopamine agonist and gonadotropin releasing hormone antagonist: a case series. Fertil Steril 2009 92 (3) 1169, e15-e17
22. Lainas T G., Sfontouris I A., Zorzovilis I Z., Petsas G K., Lainas G T., Kolibianakis E M. Management of severe early ovarian hyperstimulation syndrome by re-initiation of GnRH antagonist. Reprod Biomed Online 2007 15 (4) 408-412
23. Lainas T G., Sfontouris I A., Zorzovilis I Z. et al. Management of severe OHSS using GnRH antagonist and blastocyst cryopreservation in PCOS patients treated with long protocol. Reprod Biomed Online 2009 18 (1) 15-20
24. Mills M S., Eddowes H A., Fox R, Wardle P G. Subclavian vein thrombosis: a late complication of ovarian hyperstimulation syndrome. Hum Reprod 1992 7 (3) 370-371
25. Hignett M, Spence J E., Claman P. Internal jugular vein thrombosis: a late complication of ovarian hyperstimulation syndrome despite mini-dose heparin prophylaxis. Hum Reprod 1995 10 (12) 3121-3123
26. Kodama H, Fukuda J, Karube H, Matsui T, Shimizu Y, Tanaka T. Status of the coagulation and fibrinolytic systems in ovarian hyperstimulation syndrome. Fertil Steril 1996 66 (3) 417-424
27. Katz Z, Lancet M, Borenstein R, Chemke J. Absence of teratogenicity of indomethacin in ovarian hyperstimulation syndrome. Int J Fertil 1984 29 (3) 186-188
28. Bar-Hava I, Orvieto R, Dicker D, Dekel A, Peley D, Ben-Rafael Z. A severe case of ovarian hyperstimulation syndrome: 65 liters of ascites aspirated in an on-going IVF-ET twin pregnancy. Gynecol Endocrinol 1995 9 (4) 295-298
29. Rabau E, David A, Serr D M., Mashiach S, Lunenfeld B. Human menopausal gonadotropins for anovulation and sterility. Results of 7 years of treatment. Am J Obstet Gynecol 1967 98 (1) 92-98
30. Thaler I, Yoffe N, Kaftory J K., Brandes J M. Treatment of ovarian hyperstimulation syndrome: the physiologic basis for a modified approach. Fertil Steril 1981 36 (1) 110-113
31. Padilla S L., Zamaria S, Baramki T A., Garcia J E. Abdominal paracentesis for the ovarian hyperstimulation syndrome with severe pulmonary compromise. Fertil Steril 1990 53 (2) 365-367
32. Al-Ramahi M, Leader A, Claman P, Spence J. A novel approach to the treatment of ascites associated with ovarian hyperstimulation syndrome. Hum Reprod 1997 12 (12) 2614-2616
33. Abuzeid M I., Nassar Z, Massaad Z, Weiss M, Ashraf M, Fakih M. Pigtail catheter for the treatment of ascites associated with ovarian hyperstimulation syndrome. Hum Reprod 2003 18 (2) 370-373
34. Grochowski D, Sola E, Kulikowski M, Kuczyski W, Woczyski S, Szamatowicz M. Successful outcome of severe ovarian hyperstimulation syndrome (OHSS) with 27 liters of ascitic fluid removed by paracentesis. J Assist Reprod Genet 1995 12 (6) 394-396
35. Raziel A, Friedler S, Schachter M, Strassburger D, Bukovsky I, Ron-El R. Transvaginal drainage of ascites as an alternative to abdominal paracentesis in patients with severe ovarian hyperstimulation syndrome, obesity, and generalized edema. Fertil Steril 1998 69 (4) 780-783
36. Ozgun M T., Batukan C, Oner G, Uludag S, Aygen E M., Sahin Y. Removal of ascites up to 7.5 liters on one occasion and 45 liters in total may be safe in patients with severe ovarian hyperstimulation syndrome. Gynecol Endocrinol 2008 24 (11) 656-658
37. Ceyhan S T., Goktolga U, Karasahin E, Alanbay I, Duru N K. Continuous vaginal and bilateral thoracic fluid drainage for management of severe ovarian hyperstimulation syndrome. Gynecol Endocrinol 2008 24 (9) 505-507
38. Friedler S, Rachstein A, Bukovsky I, Ron-El R, Raziel A. Unilateral hydrothorax as a sole and recurrent manifestation of ovarian hyperstimulation syndrome following in-vitro fertilization. Hum Reprod 1998 13 (4) 859-861
39. Rinaldi M L., Spirtos N J. Chest tube drainage of pleural effusion correcting abdominal ascites in a patient with severe ovarian hyperstimulation syndrome: a case report. Fertil Steril 1995 63 (5) 1114-1117
40. Shrivastav P, Nadkarni P, Craft I. Day care management of severe ovarian hyperstimulation syndrome avoids hospitalization and morbidity. Hum Reprod 1994 9 (5) 812-814
41. Aboulghar M A., Mansour R T., Serour G I., Riad R, Ramzi A M. Autotransfusion of the ascitic fluid in the treatment of severe ovarian hyperstimulation syndrome. Fertil Steril 1992 58 (5) 1056-1059
42. Stein S F., Fulenwider J T., Ansley J D. et al. Accelerated fibrinogen and platelet destruction after peritoneovenous shunting. Arch Intern Med 1981 141 (9) 1149-1151
43. Splendiani G, Mazzarella V, Tozzo C, Elli M, Casciani C U. Autologous protein reinfusion in severe ovary hyperstimulation syndrome. J Am Coll Surg 1994 179 (1) 25-28
44. Fukaya T, Chida S, Terada Y, Funayama Y, Yajima A. Treatment of severe ovarian hyperstimulation syndrome by ultrafiltration and reinfusion of ascitic fluid. Fertil Steril 1994 61 (3) 561-564
45. Koike T, Araki S, Minakami H et al. Clinical efficacy of peritoneovenous shunting for the treatment of severe ovarian hyperstimulation syndrome. Hum Reprod 2000 15 (1) 113-117
46. Csokmay J M., Yauger B J., Henne M B., Armstrong A Y., Queenan J T., Segars J H. Cost analysis model of outpatient management of ovarian hyperstimulation syndrome with paracentesis: tap early and often versus hospitalization. Fertil Steril 2010 93 (1) 167-173